Hale Benjamin P, Au Angela K, Falk Naomi S, Bhatnagar Pawan, Beer Paul M
Ophthalmic Surg Lasers Imaging Retina. 2015 Sep;46(8):888-92. doi: 10.3928/23258160-20150909-16.
A 53-year-old woman with macular and diffuse retinoschisis complicated by presumed vitreomacular traction underwent unilateral intravitreal ocriplasmin injection. Within hours after injection, she noted a loss of vision and the perception of "negative" images in the treated eye. Electrophysiologic testing revealed flat waveforms, and optical coherence tomography (OCT) showed initial decreased central macular thickness at day 1, followed by massive increased macular thickness with subfoveal neurosensory retinal detachment at 1 week. Her central macular thickness on OCT slowly returned to baseline during a period of 1 month until development of a macula-off rhegmatogenous retinal detachment at 6 months after injection. The authors believe this unique case of vitreomacular adhesion and macular schisis complicated by post-injection visual loss and electroretinography changes may offer further insight into this unusual complication.
一名53岁女性患有黄斑和弥漫性视网膜劈裂症,并伴有疑似玻璃体黄斑牵引,接受了单侧玻璃体内注射奥克纤溶酶治疗。注射后数小时内,她注意到治疗眼视力丧失,并出现“负性”图像的感觉。电生理测试显示波形平坦,光学相干断层扫描(OCT)显示第1天中心黄斑厚度最初降低,随后在1周时黄斑厚度大量增加,并伴有黄斑下神经感觉性视网膜脱离。在1个月的时间里,她OCT上的中心黄斑厚度缓慢恢复到基线水平,直到注射后6个月出现黄斑脱离的孔源性视网膜脱离。作者认为,这例伴有注射后视力丧失和视网膜电图改变的玻璃体黄斑粘连和黄斑劈裂的独特病例,可能会为这种不寻常的并发症提供进一步的见解。